Preferred Label : Pseudohypoaldosteronism, type I, autosomal dominant;
Symbol : PHA1A;
CISMeF acronym : PHA1A;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Pha I, autosomal dominant;
Description : Autosomal dominant pseudohypoaldosteronism type I is characterized by salt wasting
resulting from renal unresponsiveness to mineralocorticoids. Patients may present
with neonatal renal salt wasting with hyperkalaemic acidosis despite high aldosterone
levels. These patients improve with age and usually become asymptomatic without treatment.
Some adult patients with the disorder may have elevated aldosterone levels, but no
history of clinical disease. This observation suggests that only those infants whose
salt homeostasis is stressed by intercurrent illness and volume depletion develop
clinically recognized PHA I (summary by Geller et al., 1998). Autosomal recessive
PHA (PHA1B; 264350), caused by mutation in any one of 3 genes encoding the epithelial
sodium channel (ENaC), is a similar but more severe systemic disorder with persistence
into adulthood.;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the nuclear receptor subfamily 3, group C, member 2 gene (NR3C2,
600983.0001);
Laboratory abnormalities : Hyponatremia; Hyperkalemia; Increased serum aldosterone; Increased plasma renin activity;
Prefixed ID : #177735;
Origin ID : 177735;
UMLS CUI : C1449842;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)